容百科技(688005.SH):在韓規劃10萬噸正極產能,已建成2萬噸/年產能;正籌備北美辦事處
格隆匯7月3日丨有投資者向容百科技(688005.SH)提問,“請問一季度公司開拓海外客户有哪些?韓國工廠何時供貨於日韓歐美客户?”
容百科技回覆稱,今年一季度以來,韓國基地順利實現投產,陸續完成海外客户認證,實現百噸級批量出貨。公司在韓規劃10萬噸正極產能,已建成2萬噸/年產能。今年,公司將強化全球佈局,以韓國基地為依託,加速推進國際客户開發,優化客户結構。韓國基地的產能釋放將推動公司與日韓客户的戰略互動,並輻射歐洲、美國及東南亞市場,服務於國際客户以及中國客户的海外工廠。目前公司正在籌備北美辦事處,未來還將在歐洲佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.